Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Sidse Ørnbjerg Würtz"'
1
Abstract P4-07-04: Preoperative Plasma Concentration of MMP-9/TIMP-1 Complexes Is Not Associated with Disease Outcome in Primary Breast Cancer (N=483)
Autor: Boye Schnack Nielsen, A Schrohl, Susanne Møller, Sidse Ørnbjerg Würtz, Nils Brünner, Henning T. Mouridsen
Publikováno v: Cancer Research. 70:P4-07
Background: Plasma levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) have been reported as predictors of poor prognosis. Indeed, in a previous study of 519 primary breast cancer patients we reported that high levels of TIMP-1 were associate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b27cc276a2be30d89e7b3f845307f742
https://doi.org/10.1158/0008-5472.sabcs10-p4-07-04
Zobrazit plný text záznamu
2
Plasma and Serum Levels of Tissue Inhibitor of Metalloproteinases-1 Are Associated with Prognosis in Node-negative Breast Cancer
Autor: Pernille Briæmer Hertel, Nils Brünner, Henning T. Mouridsen, Esbern Friis, Sidse Ørnbjerg Würtz, Susanne Møller
Publikováno v: Molecular & Cellular Proteomics. 7:424-430
The tumor level of TIMP-1 has been suggested as a new prognostic marker in breast cancer. The purpose of this study was to investigate whether TIMP-1 also carries prognostic information when measured in blood as this is a much more preferable materia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40ecd14f936c05d3e5f8a7a7fe1942dc
https://doi.org/10.1074/mcp.m700305-mcp200
Zobrazit plný text záznamu
3
Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients*
Autor: Vibeke Jensen, Anne Sofie Schrohl, Ib Jarle Christensen, Ulrik Lademann, Sidse Ørnbjerg Würtz, Nils Brünner, Henning T. Mouridsen
Publikováno v: Molecular & Cellular Proteomics. 4:483-491
Several studies have demonstrated an association between high tumor tissue levels of total tissue inhibitor of metalloproteinases-1 (TIMP-1) and a poor prognosis of primary breast cancer patients. In the present study we investigated whether measurem
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b50bd712b7938ea7a7dba907afac8a
https://doi.org/10.1074/mcp.m400209-mcp200
Zobrazit plný text záznamu
5
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer
Autor: Frederik Cold, John A. Foekens, Henning T. Mouridsen, Mårten Fernö, Ib Jarle Christensen, P. B. Hertel, Marie Klintman, Martin Malmberg, Anne-Sofie Schrohl, Sidse Ørnbjerg Würtz, Nils Brünner, Per-Uno Malmström
Publikováno v: Breast Cancer Research and Treatment, 121(2), 365-371. Springer New York
In a previous study from our laboratory, high tumor levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) have been associated with an adverse response to chemotherapy in metastatic breast cancer suggesting that TIMP-1, which is known to inhibi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e69aec6b422db9d9ecdd87d5eee0bdd
https://pubmed.ncbi.nlm.nih.gov/19653096
Zobrazit plný text záznamu
6
Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment
Autor: Barry L. Dowell, Sidse Ørnbjerg Würtz, Hans Jørgen Nielsen, Nils Brünner, Irene Vejgaard Sørensen, Ib Jarle Christensen, Nanna Møller Sørensen, Gerard J. Davis, Anne-Sofie Schrohl
Publikováno v: Scandinavian journal of gastroenterology. 43(7)
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the industrialized world. About half of "curatively" resected patients develop recurrent disease within the next 3-5 years despite the lack of clinical, histological and b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68369173e4ad725bd1b05ce2ad451b0a
https://pubmed.ncbi.nlm.nih.gov/18584515
Zobrazit plný text záznamu
7
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
Autor: Luceli C. Cuasay, Warner K. Huh, Nils Brünner, Greg Ball, Kian Behbakht, Michael A. Gold, Sidse Ørnbjerg Würtz, Sharad A. Ghamande, Michael H. Silverman
Publikováno v: Gynecologic oncology. 111(1)
Objectives A6 is a novel peptide that interferes with single-chain urokinase plasminogen activator activity and has shown anti-angiogenic, anti-migratory, and anti-invasive properties. We evaluated clinical efficacy and safety of subcutaneously admin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7712f1925fca2650545943398722d85e
https://pubmed.ncbi.nlm.nih.gov/19138792
Zobrazit plný text záznamu
8
Banking of biological fluids for studies of disease-associated protein biomarkers
Autor: Rosamonde E. Banks, Elise C. Kohn, Nils Brünner, Hans Jørgen Nielsen, Anne-Sofie Schrohl, Fred C.G.J. Sweep, Sidse Ørnbjerg Würtz
Publikováno v: Molecular & Cellular Proteomics, 7, 10, pp. 2061-6
Molecular & Cellular Proteomics, 7, 2061-6
Contains fulltext : 70057.pdf (Publisher’s version ) (Closed access) With the increasing demand of providing personalized medicine the need for biobanking of biological material from individual patients has increased. Such samples are essential for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19935b810d154d50dbcf19277cc446b4
https://doi.org/10.1074/mcp.R800010-MCP200
Zobrazit plný text záznamu
9
High serum TIMP-1 correlates with poor prognosis in breast carcinoma - a validation study
Autor: Nils Brünner, Paula Kuvaja, Sidse Ørnbjerg Würtz, Anne Talvensaari-Mattila, Paavo Pääkkö, Taina Turpeenniemi-Hujanen
Publikováno v: Cancer biomarkers : section A of Disease markers. 3(6)
A number of studies have demonstrated that high tumor tissue levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) are associated with a poor prognosis in breast cancer, suggesting that TIMP-1 could be a valid prognostic marker in this disease.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80949b2d2dc4cd1d1ec922231e63c661
https://pubmed.ncbi.nlm.nih.gov/18048967
Zobrazit plný text záznamu
10
Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study
Autor: Sidse Ørnbjerg, Würtz, Susanne, Møller, Henning, Mouridsen, Pernille Briaemer, Hertel, Esbern, Friis, Nils, Brünner
Publikováno v: Molecularcellular proteomics : MCP. 7(2)
The tumor level of TIMP-1 has been suggested as a new prognostic marker in breast cancer. The purpose of this study was to investigate whether TIMP-1 also carries prognostic information when measured in blood as this is a much more preferable materia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a1fb1e0aefd7cb082f646b8d7e61f538
https://pubmed.ncbi.nlm.nih.gov/17998244
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje